Skip to main content
. 2020 Nov 20;9(11):2516. doi: 10.3390/cells9112516

Table 2.

Patient proportions in survival analysis.

Total CLAD BOS RAS
Low blood eosinophils 274 (72.9%) 83 (30.3%) 75 (27.4%) 8 (3%)
High blood eosinophils 102 (27.1%) 62 (60.8%) 38 (37.3%) 24 (23.5%)
Low BAL eosinophils 313 (83.2%) 103 (32.9%) 89 (28.4%) 14 (4.5%)
High BAL eosinophils 63 (16.8%) 42 (66.7%) 24 (38.1%) 18 (28.6%)

CLAD: chronic lung allograft dysfunction; BOS: bronchiolitis obliterans syndrome; RAS: restrictive allograft syndrome; BAL: bronchoalveolar lavage.